Back to other trials
COVID-19
The global outbreak of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a significant public health crisis, impacting communities and economies worldwide. The urgent need for an effective preventive measure has spurred the rapid development of COVID-19 vaccine candidates. Clinical trials play a pivotal role in assessing the safety, efficacy, and potential impact of these vaccines on reducing the spread of the virus.
RNA-Based COVID-19 Vaccine
ACRA is looking for participants who:

• between the ages of 18-55

• who have received 3 or 4 prior doses of a US-authorized mRNA COVID-19 vaccine

Compensation
up to $1200
Age
18-55
Duration
6 months
Visits
5